Sanofi-Aventis cancer drug trials disappoint
Health / Medicine Related News
Shares drop sharply after the French pharmaceutical company unveils disappointing results from a late-stage cancer treatment developed with its partner BiPar Sciences
Source: FT.com - Pharmaceuticals